U.S. Beverage Stock News

Copper Property CTL Pass Through Trust (OTCPK:CPPT.L) has wrapped up FY 2025 with fourth quarter total revenue of US$24.1 million and basic EPS of US$0.10, setting the tone for how investors will read the full year. Over recent periods, the trust has seen quarterly revenue stay in a tight range around US$24 million to US$25 million, while basic EPS has moved from US$0.29 in Q4 2024 to US$0.21 in Q1 2025, US$0.30 in Q2, US$0.02 in Q3 and US$0.10 in Q4. With a trailing net margin of 62.5%...

DiDi Global (OTCPK:DIDI.Y) has wrapped up FY 2025 with Q4 revenue of C¥58.4b and a basic EPS loss of C¥0.07, while the trailing twelve months show revenue of C¥226.7b and basic EPS of C¥0.21. Over recent quarters, revenue has moved from C¥53.3b in Q1 2025 to C¥58.4b in Q4 2025, with basic EPS swinging between a C¥0.49 profit and a C¥0.52 loss as net income shifted from a C¥2.4b profit in Q1 to a C¥338m loss in Q4. For investors, the combination of slim trailing net margins, forecast earnings...

BRT Apartments (BRT) has just posted its FY 2025 numbers with fourth quarter revenue of US$23.5 million, a basic EPS loss of US$0.23 and funds from operations (FFO) of US$4.9 million, setting the tone for how the year wrapped up. The company has seen quarterly revenue move from US$24.6 million in Q4 2024 to US$23.5 million in Q4 2025, while basic EPS stepped down from a loss of US$0.11 to a loss of US$0.23 over the same period. This puts the spotlight firmly on how efficiently those rental...

Universal Logistics Holdings FY 2025 earnings snapshot Universal Logistics Holdings (ULH) has posted its FY 2025 numbers, with fourth quarter revenue of US$385.4 million and EPS of US$0.14, alongside trailing twelve month revenue of about US$1.6 billion and an EPS loss of US$3.79. Over recent periods the company reported quarterly revenue of US$426.8 million and EPS of US$1.01 in Q3 2024, followed by revenue of US$396.8 million and an EPS loss of US$2.84 in Q3 2025, then the latest Q4 2025...

If you are wondering whether DaVita's share price fairly reflects the business today, you are not alone. This article focuses squarely on what you might be paying for relative to what you are getting. DaVita's stock closed at US$150.72 most recently, with returns of 1.2% over 30 days, 31.6% year to date, 5.1% over 1 year, 96.3% over 3 years and 37.2% over 5 years. These performance figures may influence how investors think about both upside potential and risk. Recent attention on DaVita has...

Gambling.com Group (GAMB) is drawing fresh attention after its latest earnings release, which paired higher fourth quarter and full year 2025 sales with a swing to net loss and a sizable intangible asset impairment. See our latest analysis for Gambling.com Group. The latest earnings release, the US$14.0m intangible impairment and the completion of a sizeable buyback program sit against a weaker share price backdrop, with the stock at US$4.21 and a 1 year total shareholder return of a 65.7%...

Buckle (NYSE:BKE) plans to accelerate its physical and digital expansion in fiscal 2026, targeting 12 to 14 new stores and a similar number of remodels. The company is prioritizing relocations into higher traffic and premium outlet centers while reporting strong performance in its women's and kids' categories. Online sales are growing at a double digit rate, supporting the decision to invest further in both e commerce and brick and mortar locations. For investors watching NYSE:BKE, the...

RadNet (NasdaqGM:RDNT) announced plans to acquire AI medical imaging firm Gleamer for nearly US$270 million. The deal has sparked debate among investors over the price tag and strategic fit of the AI-focused expansion. A short-seller report has also questioned RadNet's accounting methodology and use of certain key performance metrics. RadNet operates a large outpatient imaging network, so adding Gleamer's AI tools would plug directly into its core business of radiology services. The move...

New England Realty Associates Limited Partnership (NEN) closed out FY 2025 with Q4 revenue of US$22.6 million and a basic EPS loss of US$0.40, while trailing 12 month EPS stood at US$1.72 on revenue of US$89.2 million. The partnership has seen revenue in recent quarters move from US$20.8 million in Q4 2024 to between roughly US$21.1 million and US$23.8 million across FY 2025, with quarterly EPS ranging from earnings of US$1.20 to a loss of US$0.40. This sets up a mixed margin picture that...

Hotel Indigo Panama City Marina, a property developed by The St. Joe Company (NYSE:JOE), received IHG Hotels & Resorts' top Torchbearer Award for guest experience excellence. The Torchbearer Award recognizes hotels within the IHG system that achieve leading guest satisfaction scores and operational performance. This recognition puts a spotlight on St. Joe's hospitality operations at a time when coastal leisure travel and branded hotel experiences remain a key focus for many real estate...

If you are wondering whether Alphabet shares still offer value at today's price, it helps to step back and look at what the current market is really pricing in. The stock most recently closed at US$302.28, with returns of 1.3% over 7 days, a 2.8% decline over 30 days, a 4.1% decline year to date, and an 83.3% return over the past year, alongside returns of 199.9% over 3 years and 200.7% over 5 years. Recent coverage of Alphabet has focused on its position as a major global technology and...

In the past week, Ingersoll Rand reported stronger-than-expected fourth-quarter 2025 results and completed the acquisition of Scinomix, Inc. to expand its life sciences automation capabilities. Yet these operational positives coincided with declining organic revenue, execution concerns, and insider selling, highlighting a tension between growth ambitions and investor confidence. We’ll now examine how the stronger-than-expected earnings, alongside the Scinomix acquisition, might reshape...

Essent Group (ESNT) shares are in focus after the mortgage insurer reported flat year on year revenue of US$312.4 million that met expectations, while earnings came in below consensus estimates, shifting attention toward profitability. See our latest analysis for Essent Group. The mixed earnings reaction comes after a softer patch for the share price, with a 30 day share price return of 11.33% and a year to date share price return of a 10.17% decline. Meanwhile, the 1 year total shareholder...

Sesame Workshop has filed a lawsuit against United Parks & Resorts (NYSE:PRKS), alleging unpaid royalties and contractual breaches tied to Sesame Place attractions. The suit seeks to terminate the long running licensing agreement and obtain damages related to the use of the Sesame Street brand in United Parks & Resorts themed entertainment portfolio. The dispute centers on the Sesame Place branded parks, which rely on access to Sesame Workshop intellectual property and characters for their...

Mid-America Apartment Communities (MAA) has been drawing attention after recent share price pressure, with the stock showing negative returns over the past month, past 3 months and year. That slump is prompting closer scrutiny from income-focused REIT investors. See our latest analysis for Mid-America Apartment Communities. The latest share price of US$126.32 leaves Mid-America Apartment Communities with a 7-day share price return of a 4.9% decline and a year-to-date share price return of a...

Earlier this month, Vericel Corporation received U.S. FDA approval to begin commercial manufacturing of its MACI cartilage repair therapy at its new Burlington, Massachusetts cell therapy facility starting in the second quarter of 2026, expanding capacity for symptomatic knee cartilage defect treatment in adults. This manufacturing approval not only supports higher MACI production volumes but also strengthens Vericel’s ability to pursue potential commercialization of the therapy in markets...

Halcyon has integrated its technology with Freddie Mac's Asset and Income Modeler (AIM) to support automated dual source income assessment for self employed borrowers. The solution combines borrower provided tax returns with IRS transcripts, automating data validation for lenders using Freddie Mac loans. The capability is immediately available to approved lenders, allowing faster adoption in current mortgage underwriting workflows. For investors watching Federal Home Loan Mortgage...

If you are trying to work out whether Ocular Therapeutix at around US$8.76 is a bargain or just fairly priced, starting with a clear view of its valuation can help frame your next move. The stock has seen mixed returns, with a 14.7% decline over the last 7 days and a 4.4% decline over the last 30 days, while the 1 year return sits at 13.5% and the 3 year return at 76.6%, compared with a 57.6% decline over 5 years. Recent market attention on Ocular Therapeutix has focused on its progress as...

How BioMarin Pharmaceutical’s Recent Moves Set Up a Closer Look at Value Before we get into the numbers, if you are wondering whether BioMarin Pharmaceutical’s current share price fairly reflects its long term potential, it helps to first step back and see what the market has been doing with the stock lately. BioMarin’s share price closed at US$58.51 most recently, with returns of 4.3% decline over the past week, 3.0% decline over the past month, a 1.6% decline year to date, and a 15.7%...

Edgewise Therapeutics recently presented long-term data from its MESA open-label extension study of sevasemten in Becker muscular dystrophy at the 2026 MDA Clinical and Scientific Conference, showing multi-year stabilization of patient function and a favorable safety profile in a disease with no approved therapies. An unusually high 99% of eligible participants from earlier sevasemten trials chose to continue into the MESA extension, underscoring sustained engagement with the investigational...

In March 2026, Northern Oil and Gas, Inc. completed a follow-on equity offering of approximately US$200.00 million, issuing 7,207,208 common shares at US$27.75 each and granting underwriters a 30-day option to purchase up to an additional 1,081,081 shares. This sizable capital raise, which increases the company’s share count, highlights management’s willingness to tap equity markets to support its growth and acquisition agenda. We’ll now examine how this sizeable equity issuance, and the...

If you are wondering whether Veralto, at around US$90.20, is offering fair value right now or if the market is mispricing it, this article walks you through what the numbers actually say. The stock has recently been under pressure, with a 7 day return of a 4.4% decline, a 30 day return of a 5.1% decline and a year to date return of an 8.4% decline, adding to a 1 year return of a 7.5% decline. Recent coverage around Veralto has focused on how the newly listed business fits into the broader...

If you are wondering whether Terex shares are still offering value at current levels, you are not alone. This article will walk through what the market price might be implying about the business. The stock last closed at US$59.41, with returns of 8.0% year to date and 49.4% over the past year. However, a 4.3% decline over the last week and a 14.0% decline over the last month shows sentiment has recently cooled. These short term moves sit against a longer backdrop where Terex has also...

Exelixis recently reported quarterly adjusted earnings per share that exceeded expectations, helped by higher Cabometyx volumes and lower operating expenses, while the FDA accepted its New Drug Application for zanzalintinib in metastatic colorectal cancer with a target action date in December 2026. Alongside these results, the company reiterated its 2026 guidance and benefited from multiple upward analyst earnings estimate revisions, underscoring how regulatory milestones and disciplined...